Vyne Therapeutics Inc
Biotechnology
Healthcare
VYNE
42.59 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
1.50
52 week high
4.28
high
1.68
52 week low
1.51
previous Close
1.51
P/E ratio
market cap
44.25 M
div yield
0
net incoming
-12.16 M
-29.40 %
net profit margin
-10047.11 %
-5302.00 %
operating incoming
-13.09 M
-25.92 %
net change in cash
-13.34 M
-226.58 %
cash on hand
16.27 M
-45.13 %
top